SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Mike Grey will be speaking on a panel, Driving Life Sciences Discovery in 2011 and Beyond: Acquire or Partner? at BIOCOMS May breakfast meeting, San Diego CA.
News | 05. 04. 2011
